Steven M. Paul - 12 Sep 2025 Form 4 Insider Report for Rapport Therapeutics, Inc. (RAPP)

Reporting relationship: Director
Issuer ticker: RAPP
Reported as of: 12 Sep 2025
Net transaction value: +$1,027,111
SEC form: 4
Accepted by SEC: 15 Sep 2025, 16:05:04 UTC
Prior SEC filing: 18 Jun 2025
Next SEC filing: 30 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ Troy Ignelzi, Attorney-in-Fact

Key filing fact

Steven M. Paul filed Form 4 for Rapport Therapeutics, Inc. (RAPP) on 15 Sep 2025.

Key facts

This page summarizes Steven M. Paul's Form 4 filing for Rapport Therapeutics, Inc. (RAPP).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 15 Sep 2025, 16:05.

Change

Previous filing in this sequence was filed on 18 Jun 2025.
Current net transaction value: +$1,027,111.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001237564 Primary reporting owner

PAUL STEVEN M

Relationship: Director
Address: RAPPORT THERAPEUTICS, INC., 99 HIGH STREET, SUITE 2100, BOSTON
Signature: /s/ Troy Ignelzi, Attorney-in-Fact
Signature date: 15 Sep 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RAPP transaction

Common Stock

Purchase

Transaction value: $692,947
Shares: +28,284
Change %
Price: $24.50
Shares after: 28,284
Date: 12 Sep 2025
Ownership: By Paul Capital Strategy III Fund LLC
Footnotes: F1, F2

RAPP transaction

Common Stock

Purchase

Transaction value: $334,165
Shares: +13,382
Change %: +47%
Price: $24.97
Shares after: 41,666
Date: 12 Sep 2025
Ownership: By Paul Capital Strategy III Fund LLC
Footnotes: F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $23.90 to $24.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price at which the transactions were effected.

Footnote F2

Shares held by Paul Capital Strategy III Fund LLC. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any.

Footnote F3

The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $24.90 to $25.00 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price at which the transactions were effected.